PostEra is a biotechnology company that applies machine learning to accelerate preclinical small-molecule drug discovery. Its platform tightly integrates the Design-Make-Test cycle of medicinal chemistry and has been used across a variety of drug discovery programs. The company cites rapid development of COVID oral antiviral candidates via the COVID Moonshot and the launch of Manifold, an industry synthesis platform, as demonstrations of its approach. PostEra plans to advance a series of partnered drug discovery programs and to initiate internal drug discovery efforts. The company will also further develop its medicinal chemistry platform and announced a multi-target strategic partnership with Pfizer to establish an AI Lab. PostEra closed new equity financing to support these plans.

Total raised

$24M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2022